THC vs CBD Drug Test Detection
Drug tests look for THC metabolites. The main metabolite is THC-COOH. CBD does not become THC in the body. But CBD products can contain THC. The risk depends on the product type.
Pick: CBD isolate
CBD isolate has 0.0% THC. It is the lowest-risk choice for a drug test. Isolate comes as powder, tincture, capsule, or vape. It has no THC-COOH. A urine immunoassay will not detect it.
- THC content: 0.0%
- Detection risk: none from CBD
- Convenience: high. No need to check batch labels for THC.
Option 2: Broad-spectrum CBD
Broad-spectrum CBD has other cannabinoids. It has no THC. Some brands test at 0.0% THC. Others may have trace amounts. Ask for a certificate of analysis (COA). Look for "ND" or "not detected" for THC.
Option 3: Full-spectrum CBD
Full-spectrum CBD can contain up to 0.3% THC by federal law. Repeated use can build up THC-COOH. A 50 ng/mL urine cutoff can be crossed. Case reports show positive tests from full-spectrum CBD. The risk is real but low for some users. High doses raise the risk.
Option 4: THC-dominant products
THC-dominant products cause positive tests. A single use can show up for 1 to 3 days. Chronic use can show up for 30 days. Blood tests detect THC for hours. Saliva tests detect THC for 1 to 2 days. Hair tests detect THC for up to 90 days.
Test types and cutoffs
- Urine immunoassay: 50 ng/mL cutoff for THC-COOH
- Urine GC-MS confirmation: 15 ng/mL cutoff
- Blood: 1 to 2 ng/mL for THC
- Saliva: 1 to 50 ng/mL for THC
- Hair: 0.1 ng/mg for THC
Convenience drives product choice. CBD isolate removes the need for batch testing. Full-spectrum CBD adds flavor and other cannabinoids. But it adds detection risk. For a drug test, CBD isolate is the pick. Broad-spectrum is the next option. Full-spectrum is a gamble. THC products are a fail.